dotdailydose
Global pharmaceutical firm Mundipharma is increasing its presence in the Philippines through the extension of its flagship BETADINE® product portfolio, a leading antiseptic brand in the Philippines.
The company is introducing a range of BETADINE® products including:
- Povidone-Iodine (BETADINE®) Dry Powder Spray for wound care and Povidone-Iodine (BETADINE®) Throat Spray for throat and oral care in innovative delivery formats to meet the needs of consumers seeking antimicrobial remedies at home or on-the-go.
- BETADINE® Fresh Bliss® Daily Feminine Wash will expand the company’s footprint in the feminine wash category. BETADINE® Fresh Bliss® Daily Feminine Wash has Gentle Defense Lactic Acid and Anti-itch Avena Oats for gentle daily cleansing and protection.
- BETADINE® Cold Defense Nasal Spray, a first-of-its-kind product that offers all-natural, non-drug, non-steroidal formulation that attacks common colds at the source, shortening the duration of illness by up to two days.*
The company’s continued investment in the Philippines indicates its confidence in the country’s attractive growth outlook in the consumer healthcare market, backed by growing consumer demand for trusted brands.
“The Philippines is a high-growth ‘powerhouse’ healthcare market where access, value and product quality are drivers of consumer preference. Our aim is to ensure we are relevant to the increasing expectations of the consumer, bringing more for the millions of people beyond the fringe of traditional healthcare.” – Mundipharma CEO Raman Singh
He adds: We are doing this now by introducing a high-quality range of BETADINE® products and treatments supported by a digitally enabled network of partners and medical professionals.
Mundipharma Philippines Country Manager, Gerry Arnedo, says the company is supporting its extended BETADINE® product range with an increased distribution footprint in key urban areas nationwide, starting with the greater Manila area, followed by Cebu and Davao.
“As well as extended distribution, other investment areas include a focus on talent acquisition and training as well as the integration of digital apps and online information to improve access and education of healthcare professionals. Given the Philippines’ high rates of mobile connectivity and rising smartphone penetration, e-health and smartphone applications will be critical to improving healthcare access and knowledge,” he adds.
Mundipharma Philippines was established in 2005. It has a strong and growing presence, specialising in Pain Management, Consumer Health, Respiratory, Oncology and Oncology Supportive Care. The company employs 160 people.
For more information visit: www.mundipharma.com.sg.
